CRM1 inhibitor anti-tumor activity is enhanced with salicylates by S-phase arrest and impaired DNA-damage repair
Ontology highlight
ABSTRACT: CRM1 inhibitor anti-tumor activity is enhanced with salicylates by S-phase arrest and impaired DNA-damage repair
PROVIDER: PRJNA672285 | ENA |
REPOSITORIES: ENA
ACCESS DATA